Suchergebnisse - "Akuta, Norio"

PubPharm (705)

41

Renal safety and biochemical changes for 2 years after switching to tenofovir alafenamide from long-term other nucleotide analog treatment in patients with chronic hepatitis B

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2022

von Hosaka, T. | Suzuki, F. | Kobayashi, M. | +10

42

Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis

enthalten in: Journal of gastroenterology | 2022

von Tahata, Y. | Hikita, H. | Mochida, S. | +33

43

Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis

enthalten in: Journal of gastroenterology | 2022

von Tahata, Y. | Hikita, H. | Mochida, S. | +33

44

Ultrasensitive Assay for Hepatitis B Core-Related Antigen Predicts Hepatocellular Carcinoma Incidences During Entecavir

enthalten in: Hepatology communications | 2022

von Hosaka, T. | Suzuki, F. | Kobayashi, M. | +10

CommentIn: Hepatol Commun. 2022 Jan;6(1):5-7. - PMID 34957702

45

Dynamics of Circulating miR-122 Predict Liver Cancer and Mortality in Japanese Patients with Histopathologically Confirmed NAFLD and Severe Fibrosis Stage

enthalten in: Oncology | 2022

von Akuta, N. | Kawamura, Y. | Suzuki, F. | +11

46

Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma

enthalten in: Oncology | 2022

von Kawamura, Y. | Kobayashi, M. | Shindoh, J. | +14

47

Ultrasensitive Assay for Hepatitis B Core‐Related Antigen Predicts Hepatocellular Carcinoma Incidences During Entecavir

enthalten in: Hepatology communications | 2022

von Hosaka, T. | Suzuki, F. | Kobayashi, M. | +10

48

Favorable impact of long‐term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus : A 5‐year follow‐up study

enthalten in: Hepatology communications | 2022

von Akuta, N. | Kawamura, Y. | Fujiyama, S. | +11

49

Renal safety and biochemical changes for 2 years after switching to tenofovir alafenamide from long‐term other nucleotide analog treatment in patients with chronic hepatitis B

enthalten in: Hepatology Research | 2022

von Hosaka, T. | Suzuki, F. | Kobayashi, M. | +10

50

Prognostic Impact of Surgical Intervention After Lenvatinib Treatment for Advanced Hepatocellular Carcinoma

enthalten in: Annals of surgical oncology | 2021

von Shindoh, J. | Kawamura, Y. | Kobayashi, Y. | +5